• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在接触耐多药结核病的高度免疫受损个体中，潜伏性结核病配对试验表现不佳：是时候寻找新的诊断标志物了。

Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markers.

作者信息

Eather Geoffrey, Wilson Malcolm, Goffinet Celine, Ryan Elizabeth

机构信息

Metro South Clinical Tuberculosis Service, Woolloongabba, Australia.

Department of Respiratory Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.

出版信息

ERJ Open Res. 2024 Apr 8;10(2). doi: 10.1183/23120541.00732-2023. eCollection 2024 Mar.

DOI:10.1183/23120541.00732-2023
PMID:38590937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11000274/
Abstract

https://bit.ly/41P8vTa.

摘要

https://bit.ly/41P8vTa. （此为网址，一般保留原文不翻译）

相似文献

1
Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markers.在接触耐多药结核病的高度免疫受损个体中，潜伏性结核病配对试验表现不佳：是时候寻找新的诊断标志物了。
ERJ Open Res. 2024 Apr 8;10(2). doi: 10.1183/23120541.00732-2023. eCollection 2024 Mar.
2
Tuberculosis结核病
3
4
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.用于诊断潜伏性结核感染的干扰素-γ释放试验：一项潜在类别分析。
PLoS One. 2017 Nov 28;12(11):e0188631. doi: 10.1371/journal.pone.0188631. eCollection 2017.
5
Multidrug-resistant tuberculosis and migration to Europe.耐多药结核病与欧洲移民
Clin Microbiol Infect. 2017 Mar;23(3):141-146. doi: 10.1016/j.cmi.2016.09.009. Epub 2016 Sep 23.
6
[Evolution of IGRA researches].[IGRA研究的进展]
Kekkaku. 2008 Sep;83(9):641-52.
7
Study of CD27 and CCR4 Markers on Specific CD4 T-Cells as Immune Tools for Active and Latent Tuberculosis Management.特异性 CD4 T 细胞上 CD27 和 CCR4 标志物作为活动性和潜伏性结核病管理的免疫工具的研究。
Front Immunol. 2019 Jan 9;9:3094. doi: 10.3389/fimmu.2018.03094. eCollection 2018.
8
Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.结核分枝杆菌特异性 CD4+ T 细胞激活标志物的差异表达可区分肺外结核和潜伏感染。
Clin Infect Dis. 2020 Nov 5;71(8):1905-1911. doi: 10.1093/cid/ciz1070.
9
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.同种异体 Vγ9Vδ2 T 细胞治疗促进肺部病变修复：多药耐药结核病患者的开放性、单臂试验研究。
Front Immunol. 2021 Dec 15;12:756495. doi: 10.3389/fimmu.2021.756495. eCollection 2021.
10
Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?推进针对耐多药结核分枝杆菌潜伏性结核感染的新型诊断检测方法 - 无路可走？
Int J Infect Dis. 2020 Mar;92S:S69-S71. doi: 10.1016/j.ijid.2020.02.011. Epub 2020 Feb 28.

本文引用的文献

1
Risk factors for TB in Australia and their association with delayed treatment completion.澳大利亚结核病的风险因素及其与治疗延迟完成的关系。
Int J Tuberc Lung Dis. 2022 May 1;26(5):399-405. doi: 10.5588/ijtld.21.0111.
2
New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis.对结核病宿主转录生物标志物局限性的新见解
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1363-1365. doi: 10.1164/rccm.202109-2146ED.
3
Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario.用于炎症性肠病患者潜伏性结核筛查的干扰素-γ释放试验与结核菌素皮肤试验的比较：印度情况
Tuberc Res Treat. 2021 Jan 26;2021:6682840. doi: 10.1155/2021/6682840. eCollection 2021.
4
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection.抗原特异性 T 细胞激活可区分近期和陈旧性结核感染。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1556-1565. doi: 10.1164/rccm.202007-2686OC.
5
Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.干扰素-γ 释放试验或结核菌素皮肤试验用于潜伏性结核感染的检测和管理：系统评价和荟萃分析。
Lancet Infect Dis. 2020 Dec;20(12):1457-1469. doi: 10.1016/S1473-3099(20)30276-0. Epub 2020 Jul 13.
6
Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA.移植候选者中的潜伏性结核感染：TST 和 IGRA 的系统评价和荟萃分析。
Infection. 2019 Jun;47(3):353-361. doi: 10.1007/s15010-019-01285-7. Epub 2019 Feb 25.
7
National position statement for the management of latent tuberculosis infection.潜伏性结核感染管理的国家立场声明。
Commun Dis Intell Q Rep. 2017 Sep 1;41(3):E204-E208.
8
Preventive therapy for latent tuberculosis infection-the promise and the challenges.潜伏性结核感染的预防治疗——前景与挑战。
Int J Infect Dis. 2017 Mar;56:68-76. doi: 10.1016/j.ijid.2016.11.006. Epub 2016 Nov 18.
9
Neutrophil-to-Lymphocyte Ratio Is Associated with Impaired Interferon-Gamma Release to Phytohemagglutinin.中性粒细胞与淋巴细胞比值与植物血凝素诱导的干扰素-γ释放受损有关。
PLoS One. 2015 May 11;10(5):e0125794. doi: 10.1371/journal.pone.0125794. eCollection 2015.
10
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.移植候选者和受者的结核病风险：TBNET 共识声明。
Eur Respir J. 2012 Oct;40(4):990-1013. doi: 10.1183/09031936.00000712. Epub 2012 Apr 10.